Squamous Cell Carcinoma of the Tongue, Head, and Neck Cancer | Dr. Dino Prato

Dave Coulier, known for his role as Uncle Joey, shares his public battle with oral cancer. His journey included 35 rounds of radiation oncology and robotic surgeon, highlighting how outdated care can be even for those with access to top hospitals.Our aim is to help patients in their cancer treatment and maintain remission, focusing on effective strategies for head and neck cancer.🎯 What You’ll Learn in This Episode:- What squamous cell carcinoma of the tongue is- Why head and neck radiation can affect quality of life- The potential immune links between lymphoma and other cancers- How viral infections relate to immune suppression- What deep multi-omics testing reveals- How precision immunotherapy differs from standard protocols- Why early adaptive monitoring matters- Questions to ask before starting treatment📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Cancer treatment should not only aim for survival — but preserve the life you’re living.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493